These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 11279265)
1. Selective small-molecule inhibitors of glycogen synthase kinase-3 activity protect primary neurones from death. Cross DA; Culbert AA; Chalmers KA; Facci L; Skaper SD; Reith AD J Neurochem; 2001 Apr; 77(1):94-102. PubMed ID: 11279265 [TBL] [Abstract][Full Text] [Related]
2. GSK-3 inhibition by adenoviral FRAT1 overexpression is neuroprotective and induces Tau dephosphorylation and beta-catenin stabilisation without elevation of glycogen synthase activity. Culbert AA; Brown MJ; Frame S; Hagen T; Cross DA; Bax B; Reith AD FEBS Lett; 2001 Nov; 507(3):288-94. PubMed ID: 11696357 [TBL] [Abstract][Full Text] [Related]
3. Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Coghlan MP; Culbert AA; Cross DA; Corcoran SL; Yates JW; Pearce NJ; Rausch OL; Murphy GJ; Carter PS; Roxbee Cox L; Mills D; Brown MJ; Haigh D; Ward RW; Smith DG; Murray KJ; Reith AD; Holder JC Chem Biol; 2000 Oct; 7(10):793-803. PubMed ID: 11033082 [TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase-3 inhibitors protect central neurons against excitotoxicity. Facci L; Stevens DA; Skaper SD Neuroreport; 2003 Aug; 14(11):1467-70. PubMed ID: 12960765 [TBL] [Abstract][Full Text] [Related]
5. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3. Christian SL; Sims PV; Gold MR J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378 [TBL] [Abstract][Full Text] [Related]
6. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation. Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Cherqui G; Perret C; Capeau J Oncogene; 2001 Jan; 20(2):252-9. PubMed ID: 11313952 [TBL] [Abstract][Full Text] [Related]
7. Lithium inhibits neurite growth and tau protein kinase I/glycogen synthase kinase-3beta-dependent phosphorylation of juvenile tau in cultured hippocampal neurons. Takahashi M; Yasutake K; Tomizawa K J Neurochem; 1999 Nov; 73(5):2073-83. PubMed ID: 10537067 [TBL] [Abstract][Full Text] [Related]
8. Opposing actions of phosphatidylinositol 3-kinase and glycogen synthase kinase-3beta in the regulation of HSF-1 activity. Bijur GN; Jope RS J Neurochem; 2000 Dec; 75(6):2401-8. PubMed ID: 11080191 [TBL] [Abstract][Full Text] [Related]
9. Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal. Crowder RJ; Freeman RS J Biol Chem; 2000 Nov; 275(44):34266-71. PubMed ID: 10954722 [TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase-3 couples AKT-dependent signaling to the regulation of p21Cip1 degradation. Rössig L; Badorff C; Holzmann Y; Zeiher AM; Dimmeler S J Biol Chem; 2002 Mar; 277(12):9684-9. PubMed ID: 11779850 [TBL] [Abstract][Full Text] [Related]
11. Hypoxia activates a platelet-derived growth factor receptor/phosphatidylinositol 3-kinase/Akt pathway that results in glycogen synthase kinase-3 inactivation. Chen EY; Mazure NM; Cooper JA; Giaccia AJ Cancer Res; 2001 Mar; 61(6):2429-33. PubMed ID: 11289110 [TBL] [Abstract][Full Text] [Related]
12. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Chalecka-Franaszek E; Chuang DM Proc Natl Acad Sci U S A; 1999 Jul; 96(15):8745-50. PubMed ID: 10411946 [TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 1 regulates signaling via the glycogen synthase kinase-3beta pathway. Implications for neuroprotection. Hashimoto M; Sagara Y; Langford D; Everall IP; Mallory M; Everson A; Digicaylioglu M; Masliah E J Biol Chem; 2002 Sep; 277(36):32985-91. PubMed ID: 12095987 [TBL] [Abstract][Full Text] [Related]
14. Essential role for protein kinase B (PKB) in insulin-induced glycogen synthase kinase 3 inactivation. Characterization of dominant-negative mutant of PKB. van Weeren PC; de Bruyn KM; de Vries-Smits AM; van Lint J; Burgering BM J Biol Chem; 1998 May; 273(21):13150-6. PubMed ID: 9582355 [TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide activates Akt in human alveolar macrophages resulting in nuclear accumulation and transcriptional activity of beta-catenin. Monick MM; Carter AB; Robeff PK; Flaherty DM; Peterson MW; Hunninghake GW J Immunol; 2001 Apr; 166(7):4713-20. PubMed ID: 11254732 [TBL] [Abstract][Full Text] [Related]
16. Corticotropin-releasing factor (CRF) and related peptides confer neuroprotection via type 1 CRF receptors. Facci L; Stevens DA; Pangallo M; Franceschini D; Skaper SD; Strijbos PJ Neuropharmacology; 2003 Oct; 45(5):623-36. PubMed ID: 12941376 [TBL] [Abstract][Full Text] [Related]
17. Roles of Akt and glycogen synthase kinase 3beta in the ultraviolet B induction of cyclooxygenase-2 transcription in human keratinocytes. Tang Q; Gonzales M; Inoue H; Bowden GT Cancer Res; 2001 Jun; 61(11):4329-32. PubMed ID: 11389054 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression. Lochhead PA; Coghlan M; Rice SQ; Sutherland C Diabetes; 2001 May; 50(5):937-46. PubMed ID: 11334436 [TBL] [Abstract][Full Text] [Related]